Accident Compensation Corp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$1.3M Buy
41,844
+8,538
+26% +$290K 0.26% 92
2020
Q1
$1.03M Hold
33,306
0.27% 87
2019
Q4
$1.24M Buy
33,306
+28,036
+532% +$999K 0.28% 91
2019
Q3
$180K Hold
5,270
0.04% 111
2019
Q2
$217K Buy
+5,270
New +$209K 0.05% 116
2018
Q4
Sell
-11,067
Closed -$463K 129
2018
Q3
$463K Sell
11,067
-4,216
-28% -$162K 0.14% 97
2018
Q2
$526K Buy
+15,283
New +$522K 0.15% 98

Other funds holding PFE

Accident Compensation Corp's PFE Position: Q2 2020 in Review

Accident Compensation Corp increased its Pfizer (PFE) stake by 26% in Q2 2020, buying an estimated $290K and bringing the position to 41,844 shares worth $1.3M. The position accounts for 0.26% of the portfolio, ranked #92.

Accident Compensation Corp first reported a position in PFE in Q2 2018 and has held it in 7 quarters since. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Accident Compensation Corp held 41,844 shares of Pfizer worth $1.3M as of Q2 2020.
  • Accident Compensation Corp bought 8,538 Pfizer shares in Q2 2020, an estimated $290K.
  • Pfizer made up 0.26% of Accident Compensation Corp's portfolio in Q2 2020, its #92 holding.
  • Accident Compensation Corp first reported a position in Pfizer in Q2 2018 and has held it in 7 quarters since.
  • 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Accident Compensation Corp's 13F filing for Q2 2020, filed 14 Aug 2020.